Advanced Proteome Therapeutics Corporation (APTCF)

USD 0.0

(0.0%)

Gross Profit Summary of Advanced Proteome Therapeutics Corporation

  • Advanced Proteome Therapeutics Corporation's latest annual gross profit in 2023 was - USD , up 100.0% from previous year.
  • Advanced Proteome Therapeutics Corporation's latest quarterly gross profit in 2024 Q1 was - USD , down 0.0% from previous quarter.
  • Advanced Proteome Therapeutics Corporation reported a annual gross profit of -4597.46 USD in annual gross profit 2022, down -55.51% from previous year.
  • Advanced Proteome Therapeutics Corporation reported a annual gross profit of -2956.30 USD in annual gross profit 2021, up 9.28% from previous year.
  • Advanced Proteome Therapeutics Corporation reported a quarterly gross profit of - USD for 2023 Q4, up 100.0% from previous quarter.
  • Advanced Proteome Therapeutics Corporation reported a quarterly gross profit of -1248.68 USD for 2023 Q2, down -9.77% from previous quarter.

Annual Gross Profit Chart of Advanced Proteome Therapeutics Corporation (2023 - 1997)

Historical Annual Gross Profit of Advanced Proteome Therapeutics Corporation (2023 - 1997)

Year Gross Profit Gross Profit Growth
2023 - USD 100.0%
2022 -4597.46 USD -55.51%
2021 -2956.30 USD 9.28%
2020 -3258.85 USD 22.71%
2019 -4216.52 USD 26.07%
2018 -5703.06 USD 35.3%
2017 -8814.55 USD 27.24%
2016 -12.11 Thousand USD -117945.41%
2015 -10.26 USD 48.9%
2014 -20.08 USD -6.02%
2013 -18.94 USD 0.0%
2012 - USD -100.0%
2011 4350.00 USD -49.58%
2010 8628.00 USD -83.0%
2009 50.76 Thousand USD -46.27%
2008 94.47 Thousand USD 60.32%
2007 58.93 Thousand USD 0.0%
2006 - USD -100.0%
2005 226.87 Thousand USD -11.89%
2004 257.48 Thousand USD -30.57%
2003 370.86 Thousand USD -34.76%
2002 568.46 Thousand USD 11.21%
2001 511.17 Thousand USD -30.51%
2000 735.64 Thousand USD -57.43%
1999 1.72 Million USD -6.7%
1998 1.85 Million USD -55.98%
1997 4.2 Million USD 0.0%

Peer Gross Profit Comparison of Advanced Proteome Therapeutics Corporation

Name Gross Profit Gross Profit Difference
Burzynski Research Institute, Inc. - USD NaN%
Arch Therapeutics, Inc. -2439.00 USD 100.0%
Evofem Biosciences, Inc. 11.7 Million USD 100.0%
Nascent Biotech, Inc. -319.5 Thousand USD 100.0%
Rebus Holdings, Inc. - USD NaN%
Santhera Pharmaceuticals Holding AG 119.1 Million USD 100.0%
Qrons Inc. - USD NaN%
Adynxx, Inc. - USD NaN%
Neon Bloom, Inc. - USD NaN%
Northwest Biotherapeutics, Inc. -25.79 Million USD 100.0%
ProtoKinetix, Incorporated -48.25 Thousand USD 100.0%
Skye Bioscience, Inc. -124.25 Thousand USD 100.0%
Eiger BioPharmaceuticals, Inc. 14.99 Million USD 100.0%
Nanobac Pharmaceuticals, Incorporated 3102.00 USD 100.0%
Institute of Biomedical Research Corp. - USD NaN%
SQZ Biotechnologies Company 9.79 Million USD 100.0%
Intellipharmaceutics International Inc. 65.72 Thousand USD 100.0%
Propanc Biopharma, Inc. -34.15 Thousand USD 100.0%
Mesoblast Limited -35.16 Million USD 100.0%
Marizyme, Inc. 457.7 Thousand USD 100.0%
Genus plc 178.7 Million USD 100.0%
VioQuest Pharmaceuticals, Inc. - USD NaN%
Pharming Group N.V. 220.1 Million USD 100.0%
Therapeutic Solutions International, Inc. 62.22 Thousand USD 100.0%
CNBX Pharmaceuticals Inc. 410.16 Thousand USD 100.0%
Nymox Pharmaceutical Corporation -11 Thousand USD 100.0%
ContraFect Corporation -154 Thousand USD 100.0%
PsyBio Therapeutics Corp. -50 Thousand USD 100.0%
Sienna Biopharmaceuticals, Inc. - USD NaN%
RegeneRx Biopharmaceuticals, Inc. 76.76 Thousand USD 100.0%
IMV Inc. -962.29 Thousand USD 100.0%
AXIM Biotechnologies, Inc. -387.5 Thousand USD 100.0%
MultiCell Technologies, Inc. 49.32 USD 100.0%
ONE Bio Corp. 20.12 Million USD 100.0%
Accustem Sciences Inc. - USD NaN%
RVL Pharmaceuticals plc 40.26 Million USD 100.0%
Arno Therapeutics, Inc. - USD NaN%
EV Biologics, Inc. 48.9 Thousand USD 100.0%
Q BioMed Inc. -8988.00 USD 100.0%
Emmaus Life Sciences, Inc. 28.25 Million USD 100.0%
Mosaic ImmunoEngineering Inc. - USD NaN%
Biomind Labs Inc. -15.42 Thousand USD 100.0%
American Oriental Bioengineering, Inc. 44.35 Million USD 100.0%
Provectus Biopharmaceuticals, Inc. -1.14 Million USD 100.0%
TetraLogic Pharmaceuticals Corporation - USD NaN%
Oncotelic Therapeutics, Inc. 70 Thousand USD 100.0%
GlobeStar Therapeutics Corporation - USD NaN%
THC Farmaceuticals, Inc. -4952.00 USD 100.0%
Acro Biomedical Co., Ltd. 140.5 Thousand USD 100.0%
Curative Biotechnology, Inc. -97.51 Thousand USD 100.0%
GB Sciences, Inc. -624.00 USD 100.0%
Alpha Cognition Inc. -86.02 Thousand USD 100.0%
HST Global, Inc. - USD NaN%
CSL Limited 7.56 Billion USD 100.0%
Wesana Health Holdings Inc. - USD NaN%
Halberd Corporation -208.00 USD 100.0%
Enzolytics Inc. 30.7 Thousand USD 100.0%
Agentix Corp. - USD NaN%
Resverlogix Corp. - USD NaN%
Nuo Therapeutics, Inc. 482.43 Thousand USD 100.0%
MetaStat, Inc. - USD NaN%
argenx SE 1.1 Billion USD 100.0%
Enzon Pharmaceuticals, Inc. - USD NaN%
Endonovo Therapeutics, Inc. -514.51 Thousand USD 100.0%
RespireRx Pharmaceuticals Inc. - USD NaN%
GeneThera, Inc. - USD NaN%
Inhibitor Therapeutics, Inc. - USD NaN%
AVAX Technologies, Inc. 617.38 Thousand USD 100.0%
Zenith Capital Corp. - USD NaN%
Genscript Biotech Corporation 409.55 Million USD 100.0%
Ember Therapeutics, Inc. - USD NaN%
Anthera Pharmaceuticals, Inc. - USD NaN%
Sigyn Therapeutics, Inc. -8856.00 USD 100.0%
WPD Pharmaceuticals Inc. - USD NaN%
Cotinga Pharmaceuticals Inc. -83.84 Thousand USD 100.0%
Kadimastem Ltd -630.13 Thousand USD 100.0%
Helix BioMedix, Inc. 987.98 Thousand USD 100.0%
VitaSpring Biomedical Co. Ltd. - USD NaN%
Capstone Therapeutics Corp. 9.61 Million USD 100.0%
BioStem Technologies, Inc. 15.42 Million USD 100.0%
Oncology Pharma Inc. - USD NaN%
Reve Technologies, Inc. - USD NaN%
LadRx Corporation -11.83 Thousand USD 100.0%
Cell Source, Inc. - USD NaN%
Regen BioPharma, Inc. 176.56 Thousand USD 100.0%
Regen BioPharma, Inc. 176.56 Thousand USD 100.0%
NovAccess Global Inc. - USD NaN%
Affymax, Inc. 1.35 Million USD 100.0%
Itoco Inc. - USD NaN%
Rasna Therapeutics, Inc. - USD NaN%
Pathfinder Cell Therapy, Inc. - USD NaN%
Mobile Lads Corp. - USD NaN%
CytoDyn Inc. -29 Thousand USD 100.0%
Claritas Pharmaceuticals, Inc. - USD NaN%
NDT Pharmaceuticals Inc. - USD NaN%
NanoSphere Health Sciences Inc. - USD NaN%
Alseres Pharmaceuticals, Inc. 450.04 Thousand USD 100.0%
SYBLEU INC 11.69 Thousand USD 100.0%
ImmunoCellular Therapeutics, Ltd. - USD NaN%
International Stem Cell Corporation 4.6 Million USD 100.0%
Bioxytran, Inc. -8285.00 USD 100.0%
GlobeImmune, Inc. - USD NaN%
Predictive Technology Group, Inc. - USD NaN%
ProText Mobility, Inc. - USD NaN%
Cardax, Inc. - USD NaN%
VG Life Sciences Inc. - USD NaN%
Kaleido Biosciences, Inc. - USD NaN%
Advaxis, Inc. - USD NaN%
Adhera Therapeutics, Inc. - USD NaN%
RenovaCare, Inc. - USD NaN%
Regnum Corp. - USD NaN%
Innovation Pharmaceuticals Inc. -373 Thousand USD 100.0%
Neutra Corp. 14.33 Thousand USD 100.0%
Windtree Therapeutics, Inc. -82 Thousand USD 100.0%
PureTech Health plc -1.6 Million USD 100.0%
Coeptis Therapeutics, Inc. -1 Million USD 100.0%
IXICO plc 3.27 Million USD 100.0%
IntelGenx Technologies Corp. -694 Thousand USD 100.0%
Gelesis Holdings, Inc. -1.79 Million USD 100.0%
CSL Limited 7.7 Billion USD 100.0%
Cellectis S.A. 18 Thousand USD 100.0%